Qulipta
Market Access/ News/ News/ News/ Sales and Marketing
Pfizer/Biohaven migraine drug rimegepant gets EU green light
Phil Taylor
AbbVie, Biohaven Pharmaceuticals, CGRP, migraine, Pfizer, Qulipta, Vydura
0 Comment
X
Pfizer/Biohaven migraine drug rimegepant gets EU green light
https://pharmaphorum.com/news/pfizer-biohaven-migraine-drug-rimegepant-gets-eu-green-light/
AbbVie sees bigger role for Qulipta in migraine prevention
Phil Taylor
AbbVie, Biohaven Pharmaceuticals, chronic migraine, migraine, prevention, Qulipta
0 Comment
X
AbbVie sees bigger role for Qulipta in migraine prevention
https://pharmaphorum.com/news/abbvie-sees-bigger-role-for-qulipta-in-migraine-prevention/
AbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clash
Phil Taylor
AbbVie, Biohaven Pharmaceuticals, CGRP, migraine, prevention, Qulipta
0 Comment
X
AbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clash
https://pharmaphorum.com/news/abbvies-qulipta-cleared-for-migraine-prevention-setting-up-biohaven-clash/